Peptide Receptor Radionuclide Therapy
Explore peptide research and guides on peptide receptor radionuclide therapy.
Peptide Receptor Radionuclide Therapy
Alpha-PRRT: Next-Gen Radioactive Peptide Therapy
Alpha-emitter PRRT uses peptides to deliver alpha particles directly to cancer cells. Phase 2 trials show 60% tumor shrinkage in treatment-naive patients.
Peptide Receptor Radionuclide TherapyLutathera: How Radioactive Peptides Treat Cancer
How Lutathera (177Lu-DOTATATE) delivers targeted radiation to neuroendocrine tumors via a radioactive peptide. NETTER trial data and real-world outcomes.